Študentová, H., Zemánková, A., Melichar, B., Eid, M., Poprach, A., Kopecky, J., Buchler, T., Šustrová, D., Stuhlová, Å., Dvorak, J., Donátová, Z., Vlček, P., Zycháčková, K., Katolicka, J., Blažek, T., Vrána, D., Fiala, O., Májková, P., Čepa, A. (2025). Avelumab first-line (1L) maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Updated real-world results from a national reimbursement registry.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.693